disease | |||||
新闻 | |||||
Biosimilars: Expanding Options For Inflammatory Disease Treatment The first biosimilar to be approved by the FDA for use in inflammatory diseases was infliximab-dyyb (Inflectra, Pfizer), in April 2016. Although the ...
| |||||
Unraveling gene functions from DNA to disease | Drug Discovery News ... disease. Using advanced genetics, transcriptomics, and epigenetics ... disease research. Here's a sneak peek at what's inside. Poster: single ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment